A biopsy needle leaves a bleeding tract behind. SinglePass is cauterizing it as the needle comes out
A 120-patient multicenter study of the FDA-cleared SinglePass Kronos biopsy-tract electrocautery device reported 100% technical success and no clinically significant bleeding through 30 days.